EFFECT ·Filed Jun 12, 2026

SCLX

Scilex Holding Co
BEARISH
Impact 6/10
Horizonweeks Processed3mo ago SEC9999999995-26-001971
IPO/offering going effective
Actionable Insight ▼ Bearish

The shelf effectiveness formalizes existing dilution overhang but does not create new immediate selling pressure. Monitor for any subsequent takedown notice or registration of new shares at lower prices, which would signal active dilution. The going concern opinion and minimal cash proceeds expectation suggest the company may need alternative financing soon.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
SCLX ▼ -36.82% at T+60d
SHORT call ✓ call won +36.82% · α vs SPY +40.09% · entry $8.50 → $5.37
Entry anchored
Jun 11, 03:59 PM ET
via exchange tick
T+1d
-6.47%
call +6.47% · α +8.23%
$7.95
settled 4mo ago
T+5d
-12.12%
call +12.12% · α +12.79%
$7.47
settled 3mo ago
T+20d
+11.53%
call -11.53% · α -9.75%
$9.48
settled 3mo ago
T+60d
-36.82%
call +36.82% · α +40.09%
$5.37
settled 24d ago

Price Chart

Loading chart...

Executive Summary

Scilex Holding Co's S-3 shelf registration (File No. 333-296430) became effective on June 11, 2026. This allows the company to sell up to 2,083,067 primary shares issuable upon exercise of outstanding warrants and conversion of convertible notes, plus up to 6,581,004 resale shares and 490,617 warrants held by selling securityholders. The effectiveness activates a dilution overhang, though warrant exercise prices far exceed the current stock price, making cash exercise unlikely.

Key Facts

  • S-3 shelf registration (File No. 333-296430) declared effective on June 11, 2026.
  • Registration covers up to 2,083,067 primary shares issuable upon exercise of warrants and conversion of convertible notes.
  • Registration also covers up to 6,581,004 resale shares and 490,617 warrants held by selling securityholders.
  • Warrant exercise prices range from $22.72 to $402.50, far above the stock's recent close of $7.99 (as of June 1, 2026).
  • Company expects little to no cash proceeds from warrant exercises.
  • Cross-filing context includes a going concern audit opinion and a complex capital structure with heavy dilution overhang.

Financial Impact

Potential dilution from up to 8.66 million shares (primary + resale) on a market cap of $74M, but cash proceeds expected to be minimal due to out-of-the-money warrants.

dilutionshare countcapital structure

Risk Factors

  • Potential for active share issuance if the company finds a buyer at current depressed prices.
  • Going concern audit opinion indicates risk of insolvency without additional capital.
  • Warrant overhang may cap any upside rally as holders could sell into strength.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001971
Document: 9999999995-26-001971-index.html9999999995-26-001971
Document: 9999999995-26-001971.txt9999999995-26-001971
11 reports for SCLX
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +34.62%Jun 29, 2026
Filters
Rows
Reports for SCLX — sortable, filterable
TypeNow
Jul 22, 2026
10w ago
8-K
MIXED ★ 5/10
$7.39 $5.80▼ −21.52%▼ −24.82%$4.06 (−45.06%)
Jul 6, 2026
12w ago
8-K
MIXED ★ 6/10
$8.07 $6.67▼ −17.41%▼ −16.84%$4.06 (−49.69%)
Jun 29, 2026
13w ago
8-K
BEARISH ★ 7/10
$7.80 $7.03▲ +9.87%▲ +8.84%$4.06 (+47.95%)
Jun 12, 2026
16w ago
Press Release
NEUTRAL ★ 2/10
$8.50 $9.48▲ +11.53%▲ +9.75%$4.06 (−52.24%)
Jun 12, 2026
16w ago
EFFECT
BEARISH ★ 6/10
$8.50 $9.48▼ −11.53%▼ −9.75%$4.06 (+52.24%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 2/10
$8.70 $9.20▲ +5.75%▲ +3.86%$4.06 (−53.33%)
Jun 4, 2026
17w ago
Press Release
NEUTRAL ★ 4/10
$4.72 $7.81▲ +65.47%▲ +66.85%$4.06 (−13.98%)
May 5, 2026
21w ago
Press Release
BULLISH ★ 8/10
$6.68 $4.46▼ −33.18%▼ −37.39%$4.06 (−39.23%)
May 4, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$6.94 $4.61▼ −33.63%▼ −39.42%$4.06 (−41.52%)
Apr 17, 2026
24w ago
Insider Cluster
MIXED ★ 6/10
$4.30 $3.92▼ −8.84%▼ −12.93%$4.06 (−5.50%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (56h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access